Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Pepstatin A: Aspartic Protease Inhibitor in Viral and Bon...
2025-10-01
Pepstatin A redefines experimental precision in viral protein processing and osteoclast differentiation studies by offering potent, selective inhibition of aspartic proteases. Its optimized workflow integration and troubleshooting strategies accelerate discovery in immunopathology, making it indispensable for advanced cell culture and infection models.
-
DRB: A Powerful Transcriptional Elongation Inhibitor for ...
2025-09-30
Unlock the full research potential of DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole)—a gold-standard transcriptional elongation and CDK inhibitor. Discover optimized protocols, advanced use-cases in HIV and cell fate studies, and robust troubleshooting strategies for maximizing experimental success.
-
Panobinostat (LBH589): Epigenetic Engineering and Apoptos...
2025-09-29
Explore how Panobinostat (LBH589), a broad-spectrum hydroxamic acid-based histone deacetylase inhibitor, uniquely advances epigenetic regulation research by linking HDAC inhibition to novel apoptosis pathways. Discover a fresh, mechanistic perspective on cell death in cancer biology.
-
EZ Cap™ Firefly Luciferase mRNA: Engineering Next-Level m...
2025-09-28
Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure advances mRNA delivery, stability, and ATP-dependent D-luciferin oxidation for robust bioluminescent reporter assays. This article uniquely dissects molecular engineering strategies underpinning enhanced transcription efficiency and in vivo imaging applications.
-
SR-202 (PPAR Antagonist): Unveiling PPARγ Inhibition in M...
2025-09-27
Explore SR-202, a selective PPAR antagonist, and its unique application in dissecting PPAR-dependent macrophage polarization within the immunometabolic axis. This in-depth analysis provides novel scientific perspectives for type 2 diabetes and obesity research.
-
Murine RNase Inhibitor: Next-Gen RNA Protection for Preci...
2025-09-26
Discover how Murine RNase Inhibitor uniquely safeguards RNA integrity in advanced molecular biology assays. Explore its oxidation-resistant mechanism, its critical role in RNA-targeted technologies, and how it propels next-generation research beyond conventional applications.
-
10 mM dNTP Mixture: Engineering Precision in DNA Synthesi...
2025-09-25
Explore how the 10 mM dNTP mixture serves as an equimolar dNTP solution for PCR and advanced DNA delivery systems. This article uniquely examines its role in optimizing nucleotide substrate balance for efficient DNA polymerase activity and intracellular trafficking.
-
Panobinostat (LBH589): Precision Epigenetic Tools for Dec...
2025-09-24
Discover how Panobinostat (LBH589), a hydroxamic acid-based histone deacetylase inhibitor, serves as a precision tool for advanced epigenetic regulation research and elucidating apoptosis induction in cancer cells. This article uniquely explores its role in dissecting caspase activation pathways, resistance mechanisms, and experimental strategies beyond conventional HDAC inhibition.
-
Tamoxifen: Multifaceted Research Applications Beyond Estr...
2025-09-23
Explore the diverse research uses of Tamoxifen, a selective estrogen receptor modulator, in fields spanning gene knockout, kinase inhibition, and antiviral studies. This article highlights Tamoxifen’s mechanistic versatility and practical guidance for advanced scientific applications.
-
We next considered the effect of
2025-03-03
We next considered the effect of alkyl chain length on the inhibitory activity. As can be seen from , it is obvious that there is no proportional relationship between the methylene chain length and activity. The activity decreased when the chain length increased from 1 to 3 and increased with elonga
-
In our previous study we showed that normal
2025-03-03
In our previous study we showed that normal and cancerous rad51 of kidney exhibit the activity of alcohol dehydrogenase and aldehyde dehydrogenase. Furthermore, the activity of class I ADH isoenzymes and total ADH were significantly higher in cancer tissue than in unchanged renal cells. Moreover, t
-
Heart failure is a chronic syndrome in which
2025-03-03
Heart failure is a chronic syndrome in which the heart is unable of pumping an adequate supply of blood to meet the metabolic requirements of the body or generating the required elevated ventricular filling pressures to maintain output [34]. Despite considerable advances in the treatment of heart fa
-
br Experimental section br Results
2025-03-03
Experimental section Results and discussion Conclusions We present a simple, sensitive and selective assay of ADA activity and its inhibitor using the enzyme catalyzed reaction and the different interaction intensity of dye-labeled AD aptamer, aptamer/AD complex with GO. The as-proposed met
-
This study was funded and
2025-03-03
This study was funded and supported by Tehran University of Medical Sciences and Health Services; and Iran National Science Foundation. Introduction The enzyme acetylcholinesterase (AChE) plays a central role in the signal transduction in the nervous system, hydrolyzing the neurotransmitter acet
-
The exact etiology of BPH is not completely understood
2025-03-03
The exact etiology of BPH is not completely understood, however this pathology has been associated with elevated AG-221 levels of the androgen DHT (10). Thus, a valuable strategy in BHP treatment is the reduction of DHT (10) levels, by inhibiting its biosynthetic production [6], [8]. An important ph